Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
about
Neuroimaging characteristics of dementia with Lewy bodies.Molecular imaging biomarkers for dementia with Lewy bodies: an update.PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Bridging molecular genetics and biomarkers in lewy body and related disordersThe monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease.Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patientsUse of psychostimulants in patients with dementia.Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats.Dementia with Lewy bodies is associated with higher scores on the Geriatric Depression Scale than is Alzheimer's disease.Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features.Radio-guided sentinel lymph node identification by lymphoscintigraphy fused with an anatomical vector profile: clinical applications.Apathy in rapid eye movement sleep behaviour disorder is common and under-recognized.Correlation between clinical symptoms and striatal DAT uptake in patients with DLB.123I-FP-CIT SPECT findings and its clinical relevance in prodromal dementia with Lewy bodies.Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies.Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease.Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease.Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction.
P2860
Q30836861-1CC420FB-8EDC-4ED2-B5B1-0D1D69C2E21CQ30881333-3FFBDAD8-BF57-4753-A6C3-065D9A5DC521Q33637285-7036A557-4399-4AFB-96CF-4FCCD1DB1ECDQ33731267-8106E2AD-4580-4EF9-86A7-69D364757F9BQ35094391-0264C58A-CED1-4B17-BECF-36818A927C97Q35119259-0C6BFAB3-087E-435F-BA88-BEBB01B117A5Q35781879-AD5DD40E-BFC7-40A2-A0BE-EDD9656185E0Q37782195-CFB7F4B9-89A2-456F-A974-68872C7D2AF8Q39051531-2F30E476-6743-40A1-91E7-DA02D023DD73Q39059417-B6AB0B57-1977-434B-AA0F-A53A20FD066EQ39703602-C6A064AE-981E-48C6-94C1-7F1EBA9E60F4Q39709239-983D5069-64DB-4EFB-8F98-63ABA7A56E57Q40127389-F9705E71-A092-49D0-8418-76ED7C8104C8Q47664948-AA67B139-F4A8-4073-96E4-35342008928EQ47748535-470E8241-4347-4423-8A16-DA37A3E8D0F9Q47830592-0FC5BA25-D2C5-48FA-8B88-D7FF61A78AB0Q48077546-AFFE1361-8106-42EC-AB1D-FD1028E96DFAQ48142962-20B5E8AC-4094-48A2-A86E-DEA9471F0532Q48654934-E9DFB265-CF64-4177-859A-7E87F3909B68Q49463729-D5E88A6F-35A1-4303-B2B8-F8B963853786
P2860
Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Severity of neuropsychiatric s ...... es: a 123I-FP-CIT SPECT study.
@en
Severity of neuropsychiatric s ...... es: a 123I-FP-CIT SPECT study.
@nl
type
label
Severity of neuropsychiatric s ...... es: a 123I-FP-CIT SPECT study.
@en
Severity of neuropsychiatric s ...... es: a 123I-FP-CIT SPECT study.
@nl
prefLabel
Severity of neuropsychiatric s ...... es: a 123I-FP-CIT SPECT study.
@en
Severity of neuropsychiatric s ...... es: a 123I-FP-CIT SPECT study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Severity of neuropsychiatric s ...... ies: a 123I-FP-CIT SPECT study
@en
P2093
Bruno Tartaglione
Ermanno Ferrannini
Giovanni Defazio
Maria S Aniello
Michele Pennelli
Nicola M Pisciotta
P2860
P304
P356
10.1002/MDS.22702
P407
P577
2009-10-01T00:00:00Z